These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 15918537)

  • 81. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-ninth report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2015; (992):1-210, back cover. PubMed ID: 26118121
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Current state of national or international standards of interferons and cytokines].
    Kohase M
    Rinsho Byori; 1995 Apr; 43(4):324-8. PubMed ID: 7537831
    [TBL] [Abstract][Full Text] [Related]  

  • 83. WHO Expert Committee on Biological Standardization. Thirty-third report.
    World Health Organ Tech Rep Ser; 1983; 687():1-184. PubMed ID: 6195831
    [No Abstract]   [Full Text] [Related]  

  • 84. WHO Expert Committee on Biological Standardization.
    World Health Organ Tech Rep Ser; 1990; 800():1-221. PubMed ID: 2124759
    [No Abstract]   [Full Text] [Related]  

  • 85. Control of manufacture--principles and purposes.
    Luff PR
    Dev Biol Stand; 1992; 79():155-8. PubMed ID: 1286749
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Control of product batches (before and after registration). The French approach.
    Vannier P
    Dev Biol Stand; 1992; 79():179-82. PubMed ID: 1286755
    [TBL] [Abstract][Full Text] [Related]  

  • 87. WHO consultation on clinical evaluation of vaccines, 17-18 July 2014, WHO Headquarters, Geneva, Switzerland.
    Knezevic I; Moorthy V; Sheets R
    Vaccine; 2015 Apr; 33(17):1999-2003. PubMed ID: 25749249
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A global perspective on vaccine safety.
    Duclos P
    Vaccine; 2004 May; 22(15-16):2059-63. PubMed ID: 15121323
    [TBL] [Abstract][Full Text] [Related]  

  • 89. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Fiftieth report.
    World Health Organ Tech Rep Ser; 2016; (996):1-358, back cover. PubMed ID: 27514184
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The work of the OIE Biological Standards Commission.
    Edwards S
    Dev Biol (Basel); 2007; 128():5-11. PubMed ID: 18084921
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The use of essential drugs. Eighth report of the WHO Expert Committee (including the revised Model List of Essential Drugs).
    World Health Organ Tech Rep Ser; 1998; 882():1-77. PubMed ID: 9922706
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The cost of quality assurance/quality control.
    Johnson DW
    Dev Biol Stand; 1992; 79():193-200. PubMed ID: 1286758
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Development of alternative methods by the EDQM and the Biological Standardization Program].
    Buchheit KH
    ALTEX; 2001; 18(1):19-22. PubMed ID: 11248845
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Considerations for setting the specifications of vaccines.
    Minor P
    Expert Rev Vaccines; 2012 May; 11(5):579-85. PubMed ID: 22827243
    [TBL] [Abstract][Full Text] [Related]  

  • 95. WHO Expert Committee on Biological Standardization. Twenty-fourth report.
    World Health Organ Tech Rep Ser; 1972; 486():1-63. PubMed ID: 4622810
    [No Abstract]   [Full Text] [Related]  

  • 96. Alternatives to animals in the development and control of biological products for human and veterinary use. The role of the European Pharmacopoeia.
    Artiges A
    Dev Biol Stand; 1999; 101():29-35. PubMed ID: 10566772
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Recommendations and requirements for the design of bioanalytical testing used in comparability studies for biosimilar drug development.
    Cai XY; Gouty D; Baughman S; Ramakrishnan M; Cullen C
    Bioanalysis; 2011 Mar; 3(5):535-40. PubMed ID: 21388266
    [TBL] [Abstract][Full Text] [Related]  

  • 98. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2003; 908():i-viii, 1-136, back cover. PubMed ID: 12768889
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Evaluation of similar biotherapeutic products (SBPs): scientific principles and their implementation.
    Knezevic I
    Biologicals; 2011 Sep; 39(5):256-61. PubMed ID: 21907589
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Problems raising from the control of biological products employed in medicine. Control of sera, vaccines, and biological products in France].
    Desbordes J
    Ann Ist Super Sanita; 1969; 5(3-4):218-81. PubMed ID: 16089166
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.